It is now nearly twenty years since Dr Kate Campbell (1951) in Melbourne first suggested a connexion between oxygen therapy and retrolental fibroplasia (RLF) in premature babies, and seventeen years since Professor Norman Ashton and his colleagues (1953) produced the condition in kittens and demonstrated the influence of concentration of oxygen and duration of exposure. There was every reason then and now to suppose that Professor Ashton's findings were relevant to the pathogenesis of RLF in the human premature baby. Nevertheless cases of RLF still occur, and I know that some ophthalmologists on encountering this condition assume that the pediatrician responsible for the care of the baby in the neonatal period was guilty of mismanagement. My short discussion of oxygen therapy in premature babies aims to demonstrate that the occurrence of RLF does not necessarily imply negligent treatment in the neonatal period, although of course on occasions it may do, to explain some of the complexities involved in oxygen therapy and to present some of the questions that are as yet unanswered.
The two commonest situations in which oxygen treatment is given in the neonatal period are, first, in the handling of birth asphyxia in infants of any gestational age, and secondly, in the treatment of respiratory failure which mainly occurs in babies prematurely born.
Birth asphyxia: Most paediatricians today accept that the rational treatment of the baby severely asphyxiated at birth is endotracheal intubation and positive pressure ventilation of the lungs. At the Hammersmith Hospital, London, we use 40%, rather than 100%, oxygen for this purpose for reasons which have nothing to do with RLF. However, I do not think it has ever been suggested that resuscitation in the labour room with even 100% oxygen in the most immature infant has ever in itself been responsible for RLF. The time involved is probably nearly always far too short.
Respiratory failure in the premature baby: This takes two forms, the so-called respiratory distress syndrome (usually due to hyaline membrane disease), and recurrent apnceic attacks. The two conditions may coexist. The basic cause of hyaline membrane disease is a deficiency of a complex phospholipid substance which normally lines the alveoli and which has the function of reducing surface tension at the air-liquid interface. Without the presence of surfactant, as it is called, there is difficulty in maintaining expansion of the lungs, a decreased pulmonary blood flow and hence the development of right-to-left shunts, in the presence of which the administration of even 100% oxygen may be insufficient to raise the arterial oxygen content to anything approaching normal levels.
The quantity of surfactant present in the lining walls of the alveoli increases with advancing gestational age, but it is important to know that even the most immature infant weighing less than 1,000 grams at birth may have enough surfactant to maintain normal lung stability, although his reserves are much less than those of a baby born at term. Since the half-life of surfactant is only a few hours and its synthesis is dependent on normal oxygenation, body temperature and pH, surfactant deficiency may develop in a baby who has suffered intrapartum asphyxia and is far more likely to do so in babies born prematurely than in term babies. Proc. roy. Soc. Med. Volume 64 July 1971 But it follows from what I have said that even the most immature baby may suffer no respiratory distress, and oxygen therapy is by no means an essential part of the care of all prematurely born babies.
All pediatricians agree that oxygen therapy is necessary for the treatment of those premature babies who suffer from respiratory failure, but the assessment of dosage is still very difficult and the need for oxygen is dependent on a number of as yet unknown variables.
In working out a regime of oxygen therapy for these babies which will minimize the risks of retrolental fibroplasia, there is one point of crucial importance. If one believed that damage to developing retinal capillaries was caused by a high environmental oxygen concentration then that concentration would have to be strictly limited. In the past many padiatricians have acted on the assumption that any concentration over 40 % is necessarily harmful. If on the other hand one believes that retinal capillary damage is the result of too high an arterial oxygen content, then the concentration of oxygen surrounding the baby is irrelevant provided the arterial oxygen tension is not allowed to rise too high. Experiments on kittens carried out by Professor Ashton in 1964 strongly supported the latter hypothesis, but even before this date our policy in the premature baby unit at the Hammersmith Hospital, London, had been determined on the assumption that it was the arterial oxygen level that mattered and not the ambient concentration. It is obvious that if this policy is adopted arterial oxygen tension must be measured, and this has been done routinely for the past eight years in premature babies receiving oxygen therapy, the blood being sampled through an umbilical arterial catheter or, when this was not possible, via the right radial artery. The weakness of this approach is that, because of the small volumes of blood in a premature baby, it is impossible to sample frequently. Four-hourly sampling day and night has been our policy, but a continuous registration of arterial oxygen tension is required to ensure that safe limits have never been exceeded. We have aimed to keep the arterial oxygen tension between 60 and 90 mm mercury, the normal range in newborn babies, and never to allow it to rise above 160 mmHg, a figure originally chosen because it is the estimated tension for a normal newborn baby breathing 40 % oxygen. In the years 1964-7 about 350 babies were treated and there were two cases of obvious cicatricial RLF, luckily not amounting to complete blindness. These cases appeared to be due to a failure to follow our own rules, rather than the rules themselves being unsound. Neither baby was sampled for a period of nine hours, and both were then found to have arterial oxygen tensions above 160 mmHg. Both were recovering from hyaline membrane disease, and it is incidentally very important to ensure that frequent determinations of blood gas tensions are done at this time since recovery may be rapid and, unless the ambient oxygen concentration is reduced, high blood levels will occur. When we described this four-year trial (Reberton et al. 1968 ) we stated that we knew of no other cases of impairment of vision attributable to RLF. We were not aware of what we have learned subsequently from the work of Baum & Bulpitt, of Harcourt and of Mushin (see subsequent papers from this meeting).
In 1968 Dr Baum drew our attention to an old observation concerning tortuosity of retinal vessels, and he has shown that this is a sign of minimal oxygen toxicity but one not associated with impairment of vision. It is more serious that Mr Harcourt and Mr Mushin have clearly demonstrated that unobvious cicatricial RLF associated with myopia is a far from rare occurrence in our babies. Our collaboration with the Institute of Ophthalmology has been of the greatest value to us, and no pediatrician can claim an accurate assessment of the incidence of RLF in surviving premature babies unless he has had equally assiduous and expert follow-up studies.
A warning must now be issued to ophthalmologists when they are reviewing the neonatal notes of premature babies in whom they subsequently suspect or diagnose RLF. Few neonatal units are sufficiently well staffed or equipped to carry out measurements ofarterial oxygen tension routinely. However, most special care baby units are now equipped with paramagnetic oxygen analysers so that oxygen therapy is recorded in terms of ambient concentration, rather than in litres per minute, a measurement of little value. These analysers are accurate and robust but they have one important source of error; if the bungs on the water absorber are not tightly fitted, room air may be entrained when one sucks incubator air into the apparatus and a falsely low reading of oxygen concentration obtained. Each neonatal department must have a routine drill to prevent this.
I shall now consider two very important and related problems. First, is there really a threshold of arterial oxygen tension below which a premature baby's retinal vessels are safe? This is the assumption we made in planning oxygen therapy, but a time/dosage effect now seems much more likely. The development of RLF probably depends on the interaction of at least three factors: (1) The degree of immaturity of the retinal capillaries.
(2) The level of arterial oxygen tension.
(3) The duration of exposure to raised 19 Section ofOphthalmology 773 levels. Thus the assumption made by many pediatricians from Professor Ashton's workthat ambient concentrations of oxygen below 40% are always safemay be incorrect and, as with other forms of oxygen toxicity, there may be no concentration of oxygen above that in air which is harmless if administered for long enough to the very immature infant. Furthermore, the normal concentration of oxygen in air may rarely be enough to raise arterial oxygen tensions to toxic levels, since there are a few well-authenticated cases of very immature babies developing RLF when no added oxygen had ever been given. The sudden transition of the immature foetus from an intrauterine arterial Po. of between 30 and 40 mmHg to one of, say, 75 mmHg, when he is born and breathes air, may be sufficient to cause retinal damage. The second problem is connected with the first. At the Hammersmith Hospital we have wondered if, in trying to maintain arterial oxygen tension within normal limits in premature babies with respiratory failure, we are not in fact aiming too high even in terms of survival and avoidance of brain damage.
We have a number of examples of babies in whom it was impossible even with the administration of 100% oxygen to raise arterial oxygen tensions above about 45 mmHg for many hours, who have survived and who, moreover, show no evidence of any brain damage. In administering oxygen at high concentrations there is always the danger already mentioned of a quick recovery from respiratory failure and an unexpected rise in arterial oxygen tension. But there is also a quite different danger, that of oxygen toxicity to the lungs, which is dependent not on arterial oxygen levels but on the concentration breathed. Dr J S Wigglesworth at Hammersmith has shown that histological signs of oxygen damage to the lungs in fatal cases are invariable where oxygen at a concentration of 80 % has been given for four days or more. For these reasons we are now carrying out a controlled trial of oxygen therapy in newborn babies in respiratory failure, but as yet have no convincing results to report.
Probably we should be trying harder to determine if, at a given level of arterial oxygen tension, the baby's oxygen needs are in fact being met. The aim of oxygen therapy is of course to ensure an adequate supply of oxygen to the mitochondria. The adequacy of the supply will depend, not only on the arterial oxygen tension but also on the heemoglobin concentration of the blood, the cardiac output and the tissue diffusion gradient. In babies with hyaline membrane disease acidosis is both respiratory and metabolic in its origins. This combined acidosis is usually regarded as an indication for alkali therapy, but it is really more logical to regard respiratory acidosis as an indication for assisted ventilation and metabolic acidosis as an indication for raising ambient oxygen concentrations. The cyanosed baby with a Pao, of 40 mmHg is the more in need of oxygen the greater the degree of metabolic acidosis. I am not of course decrying the importance of alkali therapy. I believe the most important and the most worrying and difficult aspect of oxygen therapy and RLF to be the handling of recurrent apncea in very small premature babies. These attacks are not invariably associated with the respiratory distress syndrome, but carry a bad prognosis especially if they begin in the first 24 hours of life. It is clearly quite illogical as well as dangerous to treat an apnoeic attack by increasing the concentration of ambient oxygen, since it will not help to terminate the attack and when the infant breathes again a dangerous arterial oxygen level may be reached. However, we do have some evidence at Hammersmith that slight increases in ambient oxygen concentration may help to prevent or reduce the frequency of apnceic episodes in some of these very small immature infants. But whereas hyaline membrane disease terminates in death or recovery (to the point at which oxygen is not required) within three or four days, recurrent apnoea in the most immature infants may continue for three or four weeks. Furthermore, while it is quite practicable to monitor arterial oxygen tension for three or four days, it is undesirable to maintain arterial catheterization for more than a few days and impossible to continue repeated radial artery stabs indefinitely. The etiology of recurrent apnoea in the premature infant is far from clearly understood though it is obviously multifactorial. It is the subject of intensive study in a number of neonatal research units.
To sum up, the use of oxygen therapy always implies a calculation of the relative risks, on the one hand of hypoxvmia and its consequences if oxygen is unduly restricted or withheld, and on the other hand of toxic effects if oxygen is used in excess. Complete information on which to make a rational calculation of these risks is not available; nevertheless, it is clear that whatever decision is made, oxygen therapy must be strictly controlled and strictly monitored.
